Tenofovir alafenamide in the treatment of chronic hepatitis B: design, development, and place in therapy

Overview of attention for article published in Drug Design, Development and Therapy, November 2017

Altmetric Badge

Mentioned by

facebook: 1 Facebook page

Citations

dimensions_citation: 25 Dimensions

Readers on

mendeley: 53 Mendeley

Summary Facebook Dimensions citations

So far, Dimensions has found 25 publications that cite this research output.

25

The most recent citing publications are shown below. View all 25 publications that cite this research output on Dimensions.

Efficacy and safety of tenofovir alafenamide in patients with chronic hepatitis B exhibiting suboptimal response to entecavir

Article in World Journal of Clinical Cases (December 2023)

Development and validation of a LC–MS/MS assay for tenofovir and tenofovir alafenamide in human plasma: Application in a bioequivalence study

Article in MedPharmRes (October 2023)

Tenofovir alafenamide and tenofovir disoproxil fumarate reduce incidence of hepatocellular carcinoma in patients with chronic hepatitis B

Article in JHEP Reports (July 2023)